The Immunohistochemistry Antibody Company

Home
Products
- All Antibodies
- IHC-plus Antibodies
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
Distributors
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us

View Cart

Breast Cancer Screen 10 Tissue Microarray - LS-SBRCA10

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Technical Help email

Request an IHC Study by email

PDF Spec Sheet - click here

Catalog ID:	LS-SBRCA10
Product Name:	Breast Cancer Screen 10
Description:	36 various breast cancer specimens with stage/grade and marker data (AR, ER, PR, HER2) and 12 normal/non-neoplastic breast specimens (duplicate cores)
Format:	FFPE
Category:	Human Tumor and Normal
QA/QC:	H&E reviewed; IHC validated with a positive control antibody
Storage:	Short term RT; Long term 4ºC
Clinical History:	No
Tissue Marker:	Yes
Stage/Grade:	Yes
Core Diameter:	1.5 mm
Core Thickness:	4 µm
Cases:	48
Cores:	98
Slides Per Set:	1

LS-SBRCA10 Tissue Microarray Map

Slide Number 1

LABEL

Bst

Unk

Bst

Unk

Diagnosis Type Legend

Benign non-neoplastic

Diseased

Inflammatory

Malignant

Metastatic

Tumor

Unknown

Element Tissue Legend

Breast (Bst); Unknown (Unk);

LS-SBRCA10 Element Details

Slide	Position	Species	Gender	Age	Tissue	Diagnosis	Diagnosis Type	Androgen Receptor (AR)	ERBB2 (HER2)	Estrogen Receptor (ER)	Progesterone Receptor (PR)	TNM Tumor Classification	Tumor Stage
1	A1	Human	F	50 y	Breast (Bst)	Normal	Benign non-neoplastic	+~++, 30%	-	+~++, 15%	-
1	A2	Human	F	43 y	Breast (Bst)	Normal	Benign non-neoplastic	+~++, 20%	++	+, 5%	++, 15%
1	A3	Human	F	50 y	Breast (Bst)	Normal	Benign non-neoplastic	+~++, 20%	-	+~++, 15%	+, 5%
1	A4	Human	F	30 y	Breast (Bst)	Periductal mastitis	Inflammatory	+~++, 20%	-	+~++, 5%	++, 5%
1	A5	Human	F	52 y	Breast (Bst)	Hyperplasia	Diseased	-	-	+~++, 10%	++, 10%
1	A6	Human	F	38 y	Breast (Bst)	Hyperplasia	Diseased	-	-	+~++, 5%	++, 5%
1	A7	Human	F	41 y	Breast (Bst)	Hyperplasia	Diseased	+, 20%	-	+, 15%	++, 20%
1	A8	Human	F	40 y	Breast (Bst)	Fibrocystic changes	Diseased	+~++, 20%	+	+~++, 15%	+~++, 20%
1	A9	Human	F	41 y	Breast (Bst)	Fibrocystic changes	Diseased	+, 20%	+	+~++, 15%	++~+++, 30%
1	A10	Human	F	39 y	Breast (Bst)	Fibroadenoma	Tumor	+, 5%	+	+~++, 5%	+~++, 10%
1	A11	Human	F	16 y	Breast (Bst)	Fibroadenoma	Tumor	+, 50%	+-	++~+++, 80%	++~+++, 80%
1	A12	Human	F	34 y	Breast (Bst)	Fibroadenoma	Tumor	+~++, 30%	+	++~+++, 20%	++~+++, 20%
1	B1	Human	F	50 y	Breast (Bst)	Normal	Benign non-neoplastic	+~++, 30%	-	+~++, 15%	-
1	B2	Human	F	43 y	Breast (Bst)	Normal	Benign non-neoplastic	+~++, 20%	++	+, 5%	++, 15%
1	B3	Human	F	50 y	Breast (Bst)	Normal	Benign non-neoplastic	+~++, 20%	-	+~++, 15%	+, 5%
1	B4	Human	F	30 y	Breast (Bst)	Periductal mastitis	Inflammatory	+~++, 20%	-	+~++, 5%	++, 5%
1	B5	Human	F	52 y	Breast (Bst)	Hyperplasia	Diseased	-	-	+~++, 10%	++, 10%
1	B6	Human	F	38 y	Breast (Bst)	Hyperplasia	Diseased	-	-	+~++, 5%	++, 5%
1	B7	Human	F	41 y	Breast (Bst)	Hyperplasia	Diseased	+, 20%	-	+, 15%	++, 20%
1	B8	Human	F	40 y	Breast (Bst)	Fibrocystic changes	Diseased	+~++, 20%	+	+~++, 15%	+~++, 20%
1	B9	Human	F	41 y	Breast (Bst)	Fibrocystic changes	Diseased	+, 20%	+	+~++, 15%	++~+++, 30%
1	B10	Human	F	39 y	Breast (Bst)	Fibroadenoma	Tumor	+, 5%	+	+~++, 5%	+~++, 10%
1	B11	Human	F	16 y	Breast (Bst)	Fibroadenoma	Tumor	+, 50%	+-	++~+++, 80%	++~+++, 80%
1	B12	Human	F	34 y	Breast (Bst)	Fibroadenoma	Tumor	+~++, 30%	+	++~+++, 20%	++~+++, 20%
1	C1	Human	F	38 y	Breast (Bst)	Phyllodes sarcoma	Malignant	+~++, 10%	+~++	+~++, 10%	++~+++, 50%	TisN0M0
1	C2	Human	F	52 y	Breast (Bst)	Ductal carcinoma in situ	Malignant	+-	++~+++	+++, 80%	-	TisN0M0	I
1	C3	Human	F	33 y	Breast (Bst)	Ductal carcinoma in situ	Malignant	+-	++~+++	++, 20%	++~+++, 50%	TisN0M0	I
1	C4	Human	F	37 y	Breast (Bst)	Ductal carcinoma, infiltrating and in situ	Malignant	+~++, 20%	+	++~+++, 60%	++~+++, 50%	T3N1M1	I-II
1	C5	Human	F	53 y	Breast (Bst)	Ductal carcinoma in situ	Malignant	+, 15%	+++	-	-	TisN0M0	I
1	C6	Human	F	61 y	Breast (Bst)	Ductal papillary adenocarcinoma	Malignant	+, 15%	+	+~++, 20%	+~++, 10%	T2N0M0	I-II
1	C7	Human	F	41 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++, 5%	+	++, 5%	++~+++, 10%	T2N0M0	III
1	C8	Human	F	55 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+~++, 5%	+	+, 50%	+~++, 5%	T3N2M0	II-III
1	C9	Human	F	44 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	-	-	T3N0M0	II
1	C10	Human	F	72 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++, 20%	++~+++	-	-	T2N0M0	II
1	C11	Human	F	41 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+++	+, 5%	-	T3N2M0	II
1	C12	Human	F	18 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+-	+	+~++, 5%	+~++, 5%	T2N0M0	II-III
1	D1	Human	F	38 y	Breast (Bst)	Phyllodes sarcoma	Malignant	+~++, 10%	+~++	+~++, 10%	++~+++, 50%	TxN0M0
1	D2	Human	F	52 y	Breast (Bst)	Ductal carcinoma in situ	Malignant	+-	++~+++	+++, 80%	-	TxN0M0	I
1	D3	Human	F	33 y	Breast (Bst)	Ductal carcinoma in situ	Malignant	+-	++~+++	++, 20%	++~+++, 50%	TxN0M0	I
1	D4	Human	F	37 y	Breast (Bst)	Ductal carcinoma, infiltrating and in situ	Malignant	+~++, 20%	+	++~+++, 60%	++~+++, 50%	T3N1M1	I-II
1	D5	Human	F	53 y	Breast (Bst)	Ductal carcinoma in situ	Malignant	+, 15%	+++	-	-	TxN0M0	I
1	D6	Human	F	61 y	Breast (Bst)	Ductal papillary adenocarcinoma	Malignant	+, 15%	+	+~++, 20%	+~++, 10%	T2N0M0	I-II
1	D7	Human	F	41 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++, 5%	+	++, 5%	++~+++, 10%	T2N0M0	III
1	D8	Human	F	55 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+~++, 5%	+	+, 50%	+~++, 5%	T3N2M0	II-III
1	D9	Human	F	44 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	-	-	T3N0M0	II
1	D10	Human	F	72 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++, 20%	++~+++	-	-	T2N0M0	II
1	D11	Human	F	41 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+++	+, 5%	-	T3N2M0	II
1	D12	Human	F	18 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+-	+	+~++, 5%	+~++, 5%	T2N0M0	II-III
1	E1	Human	F	31 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+-	+++	-	-	T2N0M0	II-III
1	E2	Human	F	54 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+++	-	-	T2N0M0	II
1	E3	Human	F	75 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++, 30%	-	+, 10%	+~++, 10%	T3N0M0	III
1	E4	Human	F	30 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	-	+~++, 5%	T3N0M0	I-II
1	E5	Human	F	43 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	-	-	T3N0M0	III
1	E6	Human	F	37 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+++	-	+~++, 5%	T2N0M0	III
1	E7	Human	F	42 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+	+, 50%	++~+++, 60%	T4N2Mx	II-III
1	E8	Human	F	30 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	-	-	T2N0M0	II
1	E9	Human	F	39 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+-	++~+++, 50%	+~++, 50%	T3N0M0	I-II
1	E10	Human	F	46 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+-	+	+, 5%	-	T2N0M0	III
1	E11	Human	F	40 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	+, 10%	+~++, 10%	T3N1M0	II
1	E12	Human	F	58 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	++~+++	-	-	T3N0M0	II
1	F1	Human	F	31 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+-	+++	-	-	T2N0M0	II-III
1	F2	Human	F	54 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+++	-	-	T2N0M0	II
1	F3	Human	F	75 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++, 30%	-	+, 10%	+~++, 10%	T3N0M0	III
1	F4	Human	F	30 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	-	+~++, 5%	T3N0M0	I-II
1	F5	Human	F	43 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	-	-	T3N0M0	III
1	F6	Human	F	37 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+++	-	+~++, 5%	T2N0M0	III
1	F7	Human	F	42 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+	+, 50%	++~+++, 60%	T4N2Mx	II-III
1	F8	Human	F	30 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	-	-	T2N0M0	II
1	F9	Human	F	39 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+-	++~+++, 50%	+~++, 50%	T3N0M0	I-II
1	F10	Human	F	46 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+-	+	+, 5%	-	T2N0M0	III
1	F11	Human	F	40 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	+, 10%	+~++, 10%	T3N1M0	II
1	F12	Human	F	58 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	++~+++	-	-	T3N0M0	II
1	G1	Human	F	35 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++~+++, 60%	+++	++~+++, 30%	+~++, 10%	T2N0M0	III
1	G2	Human	F	53 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++~+++, 10%	+++	+~++, 10%	-	T2N0M0	II-III
1	G3	Human	F	50 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+	+, 5%	+, 5%	T4N3M1	II-III
1	G4	Human	F	48 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+, 5%	+-	++~+++, 30%	++~+++, 50%	T2N0M0	II-III
1	G5	Human	F	51 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+-	-	++, 50%	++~++, 15%	T3N1M0	II
1	G6	Human	F	43 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+++	-	-	T4N2Mx	II-III
1	G7	Human	F	43 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+-	+~++	-	-	T3N1M0	II-III
1	G8	Human	F	40 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+++	-	-	T3N0M0	III
1	G9	Human	F	47 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	++~+++	-	-	T3N1M0	III
1	G10	Human	F	49 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++~++, 5%	+	++~+++, 20%	++~+++, 60%	T3N1M0	II-III
1	G11	Human	F	58 y	Breast (Bst)	Infiltrating mucinous adenocarcinoma	Malignant	-	+~++	-	-	T3N2M0
1	G12	Human	F	40 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant	+-	-	++~+++, 50%	+~++, 15%	T2N0M0	III
1	G13	Unknown	U		Unknown (Unk)	Unknown	Unknown
1	H1	Human	F	35 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++~+++, 60%	+++	++~+++, 30%	+~++, 10%	T2N0M0	III
1	H2	Human	F	53 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++~+++, 10%	+++	+~++, 10%	-	T2N0M0	II-III
1	H3	Human	F	50 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+	+, 5%	+, 5%	T4N3M1	II-III
1	H4	Human	F	48 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+, 5%	+-	++~+++, 30%	++~+++, 50%	T2N0M0	II-III
1	H5	Human	F	51 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+-	-	++, 50%	++~++, 15%	T3N1M0	II
1	H6	Human	F	43 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+++	-	-	T4N2Mx	II-III
1	H7	Human	F	43 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+-	+~++	-	-	T3N1M0	II-III
1	H8	Human	F	40 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+++	-	-	T3N0M0	III
1	H9	Human	F	47 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	++~+++	-	-	T3N1M0	III
1	H10	Human	F	49 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++~++, 5%	+	++~+++, 20%	++~+++, 60%	T3N1M0	II-III
1	H11	Human	F	58 y	Breast (Bst)	Infiltrating mucinous adenocarcinoma	Malignant	-	+~++	-	-	T3N2M0
1	H12	Human	F	40 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant	+-	-	++~+++, 50%	+~++, 15%	T2N0M0	III
1	H13	Unknown	U		Unknown (Unk)	Unknown	Unknown

PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.